| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7034011 Using astaxanthin; tablet or enteric coated capsules |
| 04/25/2006 | US7033762 Single nucleotide amplification and detection by polymerase |
| 04/25/2006 | US7033760 Metallic solid supports modified with nucleic acids |
| 04/25/2006 | US7033617 Use of Anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies |
| 04/20/2006 | WO2006040558A1 Substituted adenines and the use thereof |
| 04/20/2006 | WO2006015357A9 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
| 04/20/2006 | US20060084797 High affinity TGFbeta nucleic acid ligands and inhibitors |
| 04/20/2006 | US20060084624 beta-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| 04/20/2006 | US20060084616 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR) |
| 04/19/2006 | EP1646639A2 Nucleotide phosphoramidates as anticancer agents |
| 04/19/2006 | EP1646380A2 Indolocarbazole anticancer agents and methods of using same |
| 04/19/2006 | EP1572708B1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 04/19/2006 | EP1080726B1 Agents for relieving side effects |
| 04/19/2006 | CN1761677A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/18/2006 | US7030230 Dissolving of raw materials; solvent extraction |
| 04/18/2006 | US7029868 Cell fusion assays using fluorescence resonance energy transfer |
| 04/13/2006 | WO2006038865A1 Nucleotide derivatives for the treatment of type 2 diabetes and other disorders |
| 04/13/2006 | US20060079478 improved pharmacokinetic properties; oral bioavailibility; less side effects; novel intermediates; novel methods for synthesis; help to diagnose cancer/leukemia in vitro; inhibitors of adenosine deaminase |
| 04/13/2006 | US20060079468 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(ethen-1-yl)- or -[(ethyl 2-carboxyl)ethyn-1-yl]-pyrrolo[2,3-d]pyrimidine; treating hepatitis C |
| 04/13/2006 | US20060079466 Rapamycin carbohydrate derivatives |
| 04/13/2006 | US20060078969 Regulated transcription of targeted genes and other biological events |
| 04/12/2006 | EP1645561A1 Method of synthesizing cyclic bisdinucleoside |
| 04/12/2006 | EP1644395A1 Processes for preparing 4'azido nucleoside derivatives |
| 04/12/2006 | EP1644394A2 Synthesis and compositions of 2 -terminator nucleotides |
| 04/12/2006 | EP1644392A1 Rapamycin carbohydrate derivatives |
| 04/12/2006 | EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | CN1757646A Inhibitors of nucleoside metabolism |
| 04/12/2006 | CN1250740C System and method for transgenic and targeted mutagenesis screening |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026467 High resolution typing system for pathogenic Mycobaterium tuberculosum |
| 04/11/2006 | US7026123 UTR tag assay for gene function discovery |
| 04/06/2006 | WO2006037024A2 Salts of decitabine |
| 04/06/2006 | WO2006035796A1 1-(β-D-GLYCOPYRANOSYL)-3-SUBSTITUTED NITROGENOUS HETEROCYCLIC COMPOUND, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF |
| 04/06/2006 | WO2005123755A3 Purine nucleotide derivatives |
| 04/06/2006 | US20060074046 Oral administration of decitabine salt |
| 04/06/2006 | US20060074035 Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections |
| 04/06/2006 | CA2581922A1 1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 04/06/2006 | CA2581523A1 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus |
| 04/05/2006 | EP1537134B1 Process for producing a ribofuranose |
| 04/05/2006 | EP1244667B1 Cyclohexene nucleic acids |
| 04/05/2006 | EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/04/2006 | US7022852 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 04/04/2006 | US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability |
| 04/04/2006 | US7022835 by contacting with a solution containing a metal salt, polyethylene glycol, buffer and solid with hydrophilic and hydrophobic groups and/or a hydrophilic water-containing polymer matrix; for immobilizing nucleic acids for purification and/or extension; kits for analyte detection |
| 04/04/2006 | US7022833 Process for the preparation of phosphorothioate triesters |
| 04/04/2006 | US7022727 From amorphous 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl- beta -D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; agonising an adenosine receptor; easily purified, stable, easily micronized for inhalants |
| 04/04/2006 | US7022681 Cardiovascular disorders; antiemetic agents; antiischemic agents; central nervous system disorders; dietetics |
| 04/04/2006 | US7022680 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases |
| 04/04/2006 | US7022678 Pregabalin lactose conjugates |
| 04/04/2006 | CA2231199C 1,2 chemiluminescent dioxetanes of improved performance |
| 03/30/2006 | WO2006034154A2 Salts of 5-azacytidine |
| 03/30/2006 | WO2006033709A2 Novel nucleoside derivatives |
| 03/30/2006 | WO2006032921A1 Bioreductively-activated prodrugs |
| 03/30/2006 | US20060069248 Process for producing phosphoroamidite |
| 03/30/2006 | US20060069247 Phosphitylation process |
| 03/30/2006 | US20060069060 Salts of decitabine |
| 03/30/2006 | US20060068440 Methods and device for DNA sequencing using surface enhanced Raman scattering (SERS) |
| 03/30/2006 | US20060068438 Identification of gene expression alterations underlying the aging process in mammals |
| 03/30/2006 | CA2581450A1 Bioreductively-activated prodrugs |
| 03/29/2006 | EP1639121A2 Synthesis of beta -l-2-deoxy nucleosides |
| 03/29/2006 | EP1638992A1 Viral polymerase and modulation thereof |
| 03/29/2006 | EP1638984A1 Avermectin b1 monosaccharide derivatives |
| 03/29/2006 | EP1461041A4 Preparation of intermediates useful in the synthesis of antiviral nucleosides |
| 03/29/2006 | EP1124565B1 Azido derivatives of beta-l-2'-deoxy-nucleosides for the treatment of hiv infection |
| 03/29/2006 | EP1102782B1 Structural analogs of amine bases and nucleosides |
| 03/29/2006 | EP1062840B1 Apparatus and method for a custom soft-solid hearing aid |
| 03/29/2006 | EP1034180B1 Linker nucleoside, and production and use of the same |
| 03/29/2006 | CN1247607C 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests |
| 03/28/2006 | US7019135 For therapy of viral infection |
| 03/28/2006 | US7019129 at least three radicals selected from substituted or unsubstituted aryl, heteroaryl and combinations, wherein at least two of the residues are covalently linked via an exocyclic diazo bond, and a reactive functional group providing a locus for conjugation of the quencher to a carrier |
| 03/28/2006 | US7019128 For use as fluorescently labelled chain-terminating dideoxynucleotides and chain-extending primers during polymerase chain reactions |
| 03/28/2006 | US7019127 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester |
| 03/28/2006 | US7018989 Chemical compounds |
| 03/28/2006 | US7018987 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides. |
| 03/23/2006 | WO2006030980A1 Agent and food for preventing/improving functional digestive disorder |
| 03/23/2006 | WO2006030803A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 03/23/2006 | US20060063736 Compositions and methods for inhibiting mucin-type O-linked glycosylation |
| 03/23/2006 | US20060063735 Salts of 5-azacytidine |
| 03/23/2006 | US20060063173 Charge switch nucleotides |
| 03/23/2006 | CA2580692A1 Use of glutamic acid or salts thereof in preventing or improving functional digestive disorder |
| 03/23/2006 | CA2580236A1 Purinenucleoside derivative modified in 8-position and medical use thereof |
| 03/22/2006 | EP1636247A2 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof |
| 03/22/2006 | EP1635836A2 Prodrugs of heteroaryl compounds |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP0951297B1 Detection of antigens via oligonucleotide antibody conjugates |
| 03/22/2006 | CN1751058A Process for the production of 3'-nucleoside prodrugs |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/16/2006 | WO2006028618A1 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
| 03/16/2006 | WO2004113553A3 Method of producing pure amidites and oligonucleotides |
| 03/16/2006 | US20060058520 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 03/16/2006 | US20060058259 Human t-cell,lymphocyte virus; hepatitis virus |
| 03/16/2006 | CA2579660A1 Beta-glucuronidase cleavable prodrugs of o6-alkylguanine-dna alkyltransferase inactivators |
| 03/15/2006 | EP1634888A2 Synthesis of 2'-deoxy-L-nucleosides |
| 03/15/2006 | EP1634882A1 Inosine derivative and process for producing the same |
| 03/15/2006 | EP1633766A2 Modified fluorinated nucleoside analogues |